Related Experiment Video
Updated: Apr 17, 2026
07:42
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
Published on: February 19, 2017
9.3K
Smoothing the crescent curve: sickle cell disease
Julie-An Talano1, Mitchell S Cairo2
1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and.
Hematology. American Society of Hematology. Education Program
|February 20, 2015
Summary
New stem cell therapies offer hope for sickle cell disease (SCD) patients. Advances in allogeneic stem cell transplantation and gene correction strategies are expanding curative treatment options for this inherited blood disorder.
Area of Science:
- Hematology
- Genetics
- Transplantation Medicine
Background:
- Sickle cell disease (SCD) is an inherited blood disorder caused by a specific mutation in hemoglobin.
- This mutation leads to red blood cell deformation, hemolysis, and vasoocclusion, causing severe complications like pain, organ damage, and reduced lifespan.
- Current curative therapy involves myeloablative conditioning and HLA-matched sibling stem cell transplantation.
Purpose of the Study:
- To review recent advancements in allogeneic stem cell transplantation for SCD.
- To explore novel approaches including reduced toxicity conditioning and alternative donor sources.
- To discuss the potential of autologous gene correction stem cell strategies.
Main Methods:
- Review of current literature on stem cell transplantation for SCD.
- Analysis of novel conditioning regimens and alternative donor sources (unrelated donors, cord blood, haploidentical donors).
- Evaluation of autologous gene correction stem cell strategies.
Main Results:
- Allogeneic stem cell transplantation remains the only proven cure for SCD.
- Reduced toxicity conditioning and alternative donor sources are expanding eligibility for transplantation.
- Autologous gene correction offers a promising future therapeutic avenue.
Conclusions:
- Significant progress is being made in stem cell-based therapies for SCD.
- Novel approaches are increasing the accessibility of curative treatments.
- Future strategies aim to provide stem cell and gene correction therapies to more SCD patients.
More Related Videos
Related Concept Videos
01:49Multiple Allele Traits
39.2K
The Concept of Multiple Allelism
39.2K
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:35Pedigree Analysis
91.5K
Overview
91.5K
01:27Disorders of Erythrocytes
2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K
01:24Cystic Fibrosis: Management
647
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
647
01:27Slant Asymptotes
238
A function's behavior is often guided by asymptotic constraints, where one term dominates another, defining a limiting trend. In the given scenario, the mathematical pattern follows a rational function: a cubic term in the numerator is divided by a squared term in the denominator. This results in a function with distinct characteristics, including an oblique asymptote, critical points, and undefined regions.The function's validity is determined by the denominator, which must be nonzero. This...
238